Evidence map›Paper›PMID 35787310›Full record

ArticleeLife2022

Controlling SARS-CoV-2 in schools using repetitive testing strategies.

Andrea Torneri, Lander Willem, Vittoria Colizza, Cécile Kremer, Christelle Meuris, Gilles Darcis, Niel Hens, Pieter J K Libin

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Informing quarantine policy for measles control in primary school and daycare settings: insights from a simulation study, Flanders, Belgium.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Effectiveness of SARS-CoV-2 testing strategies: A scoping review.Cochrane evidence synthesis and methods · 2023
    Review
  9. Minimising school disruption under high incidence conditions due to the Omicron variant in France, Switzerland, Italy, in January 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Andrea TorneriCentre for Health Economic Research and Modelling Infectious Diseases, University of Antwerp, Antwerp, Belgium.ORCID 0000-0002-4322-0770
Lander WillemCentre for Health Economic Research and Modelling Infectious Diseases, University of Antwerp, Antwerp, Belgium.
Vittoria ColizzaINSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France.ORCID 0000-0002-2113-2374
Cécile KremerInteruniversity Institute of Biostatistics and statistical Bioinformatics, Data Science Institute, Hasselt University, Hasselt, Belgium.
Christelle MeurisDepartment of Infectious Diseases, Liège University Hospital, Liège, Belgium.
Gilles DarcisDepartment of Infectious Diseases, Liège University Hospital, Liège, Belgium.
Niel Hens *Centre for Health Economic Research and Modelling Infectious Diseases, University of Antwerp, Antwerp, Belgium.ORCID 0000-0003-1881-0637
Pieter J K Libin *Interuniversity Institute of Biostatistics and statistical Bioinformatics, Data Science Institute, Hasselt University, Hasselt, Belgium.ORCID 0000-0003-3906-758X
University of Antwerp · BEUniversity of Liège · BEHasselt University · BETokyo Institute of Technology · JPVrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 remains a worldwide emergency. While vaccines have been approved and are widely administered, there is an ongoing debate whether children should be vaccinated or prioritized for vaccination. Therefore, in order to mitigate the spread of more transmissible SARS-CoV-2 variants among children, the use of non-pharmaceutical interventions is still warranted. We investigate the impact of different testing strategies on the SARS-CoV-2 infection dynamics in a primary school environment, using an individual-based modelling approach. Specifically, we consider three testing strategies: (1)

Indexed as

COVID-19SARS-CoV-2ChildHumansSchoolsCOVID-19epidemic controlepidemiologyglobal healthhumaninfectious diseasemicrobiologyrepetitive testing

Identifiers

PMID35787310
PMCPMC9255973
OpenAlexW4283817840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.